Seoul court fines Samsung leader Lee for unlawful sedative use - Yonhap
Reuters
Published Oct 26, 2021 04:01
Updated Oct 26, 2021 07:06
SEOUL (Reuters) - A Seoul court fined Samsung Electronics (LON:0593xq) Co Ltd Vice Chairman Jay Y. Lee 70 million won ($59,461.62) plus a fee for unlawful use of a controlled substance, Yonhap reported on Tuesday.
Seoul Central District Court fined Lee for being administered propofol, a sedative used in anaesthesia, multiple times between 2015-2020, Yonhap said.
Under South Korean law, the recipient of a controlled substance deemed to have been administered illegally is liable for prosecution, as well as those who administered the drug.
Lee has kept a low public profile since his parole in August from a bribery and embezzlement conviction in January. He remains on trial accused of stock-price manipulation and accounting fraud related to the $8 billion merger of two Samsung firms in 2015.
($1 = 1,177.2300 won)
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.